Guru Ownership Trend
Guru Analysis for Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. (VNDA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $28.62 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.38 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 118.1%. Conversely, Jeremy Grantham reduced exposure by 23.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Vanda Pharmaceuticals Inc. (VNDA)
Major holders include Cliff Asness ($21.41 M), Renaissance Technologies (RenTech) ($16.24 M), Steven Cohen ($1.91 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 7.17 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.38 M, with 1 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited VNDA. The total reported sell value was $1.45 M.
Yes, 1 managers opened new positions in VNDA, and 0 increased their existing holdings. The total reported buy value was $64,876.